卡维地洛治疗充血性心力衰竭合并快速型心房纤颤的疗效观察  

Effects of carvedilol on patients with congestive heart failure and atria fibrillations

作　　者：袁章顺[1] 袁克[1] 曾令蓉[1] 

机构地区：[1]怀化医学高等专科学校附属医院心内科,湖南怀化418000

出　　处：《医师进修杂志》2004年第1期26-28,共3页Journal of Postgraduates of Medicine

摘　　要：目的　观察卡维地洛治疗充血性心力衰竭 (CHF)合并快速型心房纤颤 (Af)的临床疗效。方法　将CHF并快速型Af患者 5 6例 ,随机分为治疗组、对照组各 2 8例。治疗组在常规治疗的基础上加用卡维地洛。对照组给予强心利尿等常规治疗。疗程均为 16周。结果　治疗组在临床疗效 (92 .86 % )、心电图疗效 (85 .72 % )以及心泵功能各项指标均明显优于对照组 (P <0 .0 1)。结论　卡维地洛治疗CHF并快速型Af,既能有效控制心室率 ,又能显著改善心功能。Objective To evaluate the effects of carvedilol on patients with congestive heart failure(CHF) and rapid atria fibrillation(Af). Methods Fifty-six patients with CHE and rapid Af were randomly divided into two groups. The patients of control group(28 cases) received routine treatment(diuretic, cardiac glycoside, etc.) The observation group(28 cases) was added with carvedilol. The whole course lasted for sixteen weeks.Results After treatment, the clinical efficiencies and electrocardiogram efficiencies in the observation group were 92.86% and 85.72%. It was clear better than routine treatment(P<0.01).Conclusion Carvedilol is effective and safe in the treatment of congestive heart failure and rapid atria fibrillation. It can both efficiently control heart rate and greatly improve cardiac function.

关 键 词：卡维地洛 充血性心力衰竭 快速型心房纤颤 药物治疗 合并症 

分 类 号：R541.61[医药卫生—心血管疾病] R541.71[医药卫生—内科学]